Ex Parte BACHMAN et al - Page 7


             Appeal No. 2001-0352                                                                                   
             Application 08/872,097                                                                                 

             elements of which claims the Examiner might be referring to by the last paragraph and                  
             we decline to speculate.                                                                               
                    It is unnecessary for us to belabor the point by illustrating the deficiencies of each          
             of the other rejections as well.  Suffice it to say, they each lack the requisite specificity          
             needed for the establishment of a prima facie case of obviousness.  As the examiner                    
             bears the initial burden of presenting a prima facie case of unpatentability (In re Oetiker,           
             977 F.2d 1443, 1445, 24 USPQ2d 1443, 1444  (Fed. Cir. 1992)), and that burden has                      
             not been met in a manner enabling proper review, we vacate the rejections and remand                   
             for the entry of appropriately written rejections.                                                     
                    However, this is not to say that we agree with the Appellants’ contention that the              
             claims are patentable.  Upon remand, the Examiner should again consider the                            
             patentability of the claims in light of the cited art.  Indeed, we suggest an independent              
             analysis for each claim pending.  Such an exemplary analysis is reproduced in the claim                
             chart, which follows (for example if one were to reject Claim 23 under §102 as                         
             anticipated by Gleave):                                                                                
             Claim 23 Elements                             Rejection                                                
             A universal fluid exchanger, comprising:      Gleave relates to the exchange of fluid in               
                                                           the extraction of an analyte while injecting             
                                                           extraction fluid (col. 2, lines 35-40)                   
             a plurality of reaction vessels;              Gleave clearly indicates provision for a                 
                                                           plurality of reaction vessels (elicitation of            
                                                           an analyte from solution can occur in a                  
                                                           reaction vessel) (see figs 2, 3, 4, and col.             
                                                           14, line 36 “one or more cells”, col. 14, line           
                                                           53 “one of cells”)                                       
             a reaction vessel support disposed to hold    Reaction vessel support 23.                              
             the plurality of reaction vessels in a                                                                 
             preferred orientation;                                                                                 
             a plurality of injection ports, each injection There is a plurality of cells present, and              

                                                         7                                                          



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007